Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enovis Corporation Common Stock (NY:ENOV)

28.44 -0.08 (-0.28%)
Official Closing Price Updated: 7:00 PM EDT, Aug 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Enovis Corporation Common Stock

< Previous 1 2 3 Next >
Enovis’s (NYSE:ENOV) Q2 Sales Beat Estimates, Stock Jumps 10.3%
Medical technology company Enovis Corporation (NYSE:ENOV) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 7.5% year on year to $564.5 million. The company’s... 
Via StockStory
Topics Earnings
Enovis Corp (NYSE:ENOV) Reports Mixed Q2 2025 Results with EPS Beat and Revenue Miss
Enovis Corp (ENOV) reported mixed Q2 2025 results, with revenue slightly missing estimates but adjusted EPS beating forecasts. Shares rose 6.9% pre-market as the company raised full-year guidance. 
Via Chartmill
Enovis (ENOV) Q2 Revenue Rises 7%
Via The Motley Fool
Topics Earnings
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Enovis Earnings: What To Look For From ENOV
Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting earnings this Thursday before market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
Earnings Scheduled For May 8, 2025
 
Via Benzinga
3 of Wall Street’s Favorite Stocks That Fall Short
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Enovis (ENOV) Stock Trades Up, Here Is Why
Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.3% in the morning session after the stock gained ground amid a broader market rally as investors looked ahead to a busy week... 
Via StockStory
Topics Lawsuit Stocks
Enovis, CONMED, Astrana Health, Privia Health, and Waters Corporation Stocks Trade Down, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
Assessing Enovis: Insights From 4 Financial Analysts
 
Via Benzinga
3 Unprofitable Stocks with Open Questions
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
Topics Artificial Intelligence
3 Value Stocks with Questionable Fundamentals
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
Entegris, Herc, Enovis, Commercial Vehicle Group, and DexCom Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.4%, S&P 500 +1.0%) on hopes the reported ceasefire between Israel and Iran will hold. This de-escalation... 
Via StockStory
Topics Economy Government Stocks
3 Stocks Under $50 in Hot Water
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
Via StockStory
1 Growth Stock to Target This Week and 2 to Be Wary Of
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who... 
Via StockStory
3 Out-of-Favor Stocks in the Doghouse
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value... 
Via StockStory
American Airlines, Omnicell, Integra LifeSciences, Enovis, and Warby Parker Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports,... 
Via StockStory
Topics Government Stocks World Trade
Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Enovis (NYSE:ENOV)
Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Enovis (NYSE:ENOV) and its peers. 
Via StockStory
3 Small-Cap Stocks with Bad Fundamentals
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
Topics Supply Chain
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
Where Enovis Stands With Analysts
 
Via Benzinga
Enovis (NYSE:ENOV) Posts Q1 Sales In Line With Estimates But Stock Drops
Medical technology company Enovis Corporation (NYSE:ENOV) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.3% year on year to $558.8 million. The company’s full-year revenue... 
Via StockStory
Enovis (ENOV) Q1 Earnings Report Preview: What To Look For
Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting results tomorrow before market hours. Here’s what to look for. 
Via StockStory
3 Dawdling Stocks in Hot Water
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
1 Unprofitable Stock with Competitive Advantages and 2 to Question
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
Reasons to Sell ENOV and 1 Stock to Buy Instead
What a brutal six months it’s been for Enovis. The stock has dropped 22.5% and now trades at $31.96, rattling many shareholders. This might have investors contemplating their next move. 
Via StockStory
Topics Economy Government World Trade
1 of Wall Street’s Favorite Stock to Target This Week and 2 to Think Twice About
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Spotting Winners: STAAR Surgical (NASDAQ:STAA) And Medical Devices & Supplies - Specialty Stocks In Q4
Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including STAAR Surgical (NASDAQ:STAA) and its peers. 
Via StockStory
Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest
Let’s dig into the relative performance of Integer Holdings (NYSE:ITGR) and its peers as we unravel the now-completed Q4 medical devices & supplies - specialty earnings season. 
Via StockStory
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.